Following a meeting with Anthony Lostracco, Manager of the Drug Shortages Unit at Health Canada this past Friday, the Canadian Epilepsy Alliance has learned that Health Canada is in contact with Teva Canada about the shortage, its future resolution, and the extent to which Health Canada may be able to assist. Our community member Rebecca…
We have learned of an anticipated drug shortage that may affect some epilepsy patients in Canada. The product shortage affects SABRIL (vigabatrin), in the 500 mg powder for oral solution only. Stock of 500 mg SABRIL tablets remains available. The shortage is expected to begin in early August, and at this time it is unknown…
Sponsor Image 1
Sponsor Image 2
Sponsor Image 3
Sponsor Image 1
Sponsor Image 2
Sponsor Image 3
